Key facts
- This page summarizes Peter Lamb's Form 4 filing for EXELIXIS, INC. (EXEL).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 08 Mar 2022, 19:52.
Peter Lamb - 04 Mar 2022 Form 4 Insider Report for EXELIXIS, INC. (EXEL)
- Reporting relationship
- EVP, Scientific Strategy & CSO
- Issuer ticker
- EXEL
- Reported as of
- 04 Mar 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 08 Mar 2022, 19:52:22 UTC
- Prior SEC filing
- 17 Feb 2022
- Next SEC filing
- 17 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher J. Senner, Attorney in Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Peter Lamb filed Form 4 for EXELIXIS, INC. (EXEL) on 08 Mar 2022.
Change
- Previous filing in this sequence was filed on 17 Feb 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EXEL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +59,490
- Change %
- +17%
- Price
- $0.000000
- Shares after
- 402,485
- Date
- 04 Mar 2022
- Ownership
- Direct
- Footnotes
- F1, F2, F3
EXEL
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 17,105
- Date
- 04 Mar 2022
- Ownership
- By 401(k)
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock.
Footnote F2
The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the original number of shares subject to the restricted stock unit award on May 15, 2023 and thereafter as to 1/4th of the original number of shares subject to the restricted stock unit award on each May 15th until fully vested.
Footnote F3
Includes 132,731 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
Footnote F4
Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of March 4, 2022.